Cargando…
Rationale and current perspective for early rhythm control therapy in atrial fibrillation
Atrial fibrillation (AF) is the most common sustained arrhythmia and an important source for mortality and morbidity on a population level. Despite the clear association between AF and death, stroke, and other cardiovascular events, there is no evidence that rhythm control treatment improves outcome...
Autores principales: | Van Gelder, Isabelle C., Haegeli, Laurent M., Brandes, Axel, Heidbuchel, Hein, Aliot, Etienne, Kautzner, Josef, Szumowski, Lukasz, Mont, Lluis, Morgan, John, Willems, Stephan, Themistoclakis, Sakis, Gulizia, Michele, Elvan, Arif, Smit, Marcelle D., Kirchhof, Paulus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198586/ https://www.ncbi.nlm.nih.gov/pubmed/21784740 http://dx.doi.org/10.1093/europace/eur192 |
Ejemplares similares
-
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation
por: Willems, Stephan, et al.
Publicado: (2019) -
Anticoagulation, therapy of concomitant conditions, and early rhythm control
therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4
trial
por: Metzner, Andreas, et al.
Publicado: (2021) -
Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial
por: Metzner, Andreas, et al.
Publicado: (2021) -
Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial
por: Willems, Stephan, et al.
Publicado: (2021) -
Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
por: Rillig, Andreas, et al.
Publicado: (2021)